Mason Hawkins Southeastern Asset Management
Mason Hawkins co-founded Southeastern Asset Management, adviser to the Longleaf Partners funds, and is a leading figure in absolute-value investing. The firm is known for concentrated portfolios, appraised-value analysis, and a long-term partnership culture with portfolio companies. Hawkins’s process emphasizes free cash flow, management alignment, and buying at a discount to intrinsic value.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Abbott
ABT
|
+$76.7M |
| 2 |
CNX Resources
CNX
|
+$23.4M |
| 3 |
Tencent Music
TME
|
+$21.1M |
| 4 |
Albertsons Companies
ACI
|
+$19.5M |
| 5 |
GLIBK
Liberty Capital Corp Series C GCI Group Common Stock
GLIBK
|
+$17.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ACM Research
ACMR
|
+$45.5M |
| 2 |
Bio-Rad Laboratories Class A
BIO
|
+$45.4M |
| 3 |
PPLI
People Inc
PPLI
|
+$38M |
| 4 |
Rayonier
RYN
|
+$26.6M |
| 5 |
TripAdvisor
TRIP
|
+$26.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 17.36% |
| 2 | Consumer Staples | 15.04% |
| 3 | Communication Services | 14.65% |
| 4 | Real Estate | 14.41% |
| 5 | Industrials | 11.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Dole
DOLE
$1.26B
| $24M | 1.25% |
1,752,155
-181,553
| -9% | -$2.64M |
|
|
27
Tencent Music
TME
$14.4B
| $19.2M | 1% |
+2,305,210
| New | +$21.1M |
|
28
New Oriental
EDU
$8.88B
| $18.9M | 0.99% |
411,598
-110,682
| -21% | -$5.63M |
|
29
Kaspi.kz JSC
KSPI
$20.1B
| $18.5M | 0.96% |
212,999
-27,629
| -11% | -$2.34M |
|
|
30
ACM Research
ACMR
$5.53B
| $17.7M | 0.92% |
139,478
-643,422
| -82% | -$45.5M |
|
|
MICC
31
The Magnum Ice Cream Company N.V.
MICC
$12.2B
| $17.4M | 0.91% |
1,001,588
-618,032
| -38% | -$9.62M |
|
32
SharkNinja
SN
$25.5B
| $9.63M | 0.5% |
63,234
-187,432
| -75% | -$22.4M |
|
33
Huazhu Hotels Group
HTHT
$15.1B
| $8.58M | 0.45% |
205,682
-25,690
| -11% | -$1.22M |
|
34
Melco Resorts & Entertainment
MLCO
$2.09B
| $8.47M | 0.44% |
1,607,854
-189,400
| -11% | -$1.06M |
|
35
Affiliated Managers Group
AMG
$9.21B
| $1.88M | 0.1% |
5,562
| – | – |
|
36
Cardinal Health
CAH
$53.4B
| $1.74M | 0.09% |
7,337
| – | – |
|
|
GLIBA
37
Liberty Capital Corp Series A GCI Group Common Stock
GLIBA
$1.04B
| $1.59M | 0.08% |
72,692
-7,983
| -10% | -$226K |
|
38
Live Nation Entertainment
LYV
$42.4B
| $1.54M | 0.08% |
8,434
| – | – |
|
39
Hyatt Hotels
H
$17B
| $1.5M | 0.08% |
7,733
| – | – |
|
40
Henry Schein
HSIC
$9.86B
| $1.42M | 0.07% |
17,038
| – | – |
|
41
XPO
XPO
$23.2B
| $1.3M | 0.07% |
6,336
| – | – |
|
42
Madison Square Garden
MSGS
$9.78B
| $1.29M | 0.07% |
3,218
| – | – |
|
43
RXO
RXO
$3.72B
| $1.21M | 0.06% |
43,731
| – | – |
|
44
PayPal
PYPL
$52.7B
| $970K | 0.05% |
22,463
| – | – |
|
45
Enovis
ENOV
$1.5B
| $916K | 0.05% |
44,258
| – | – |
|
46
Lazard
LAZ
$4.3B
| $780K | 0.04% |
18,608
| – | – |
|
47
HDFC Bank
HDB
$121B
| $270K | 0.01% |
10,462
| – | – |
|
|
48
Bio-Rad Laboratories Class A
BIO
$10.2B
| – | – |
-162,804
| Closed | -$45.4M |
|
49
Clarivate
CLVT
$1.33B
| – | – |
-121,927
| Closed | -$308K |
|
|
FISV
50
Fiserv Inc
FISV
$28B
| – | – |
-3,990
| Closed | -$223K |
|
Similar funds
Mason Hawkins's Q2 2026 Portfolio in Review
As of Q2 2026, Mason Hawkins held 51 positions worth $1.92B, down 5.7% from $2.03B the previous quarter. Its ten largest holdings account for 63% of the portfolio.
Mason Hawkins withdrew a net $136M in Q2 2026, closing 4 positions and reducing 24 holdings. Its most notable exit was Bio-Rad Laboratories Class A, an estimated $45.4M position sold in full.
By sector, the portfolio is most concentrated in Consumer Discretionary at 17% of assets, down from 20% a quarter earlier, followed by Consumer Staples and Communication Services.
Against the trend, Mason Hawkins opened a new position in Abbott worth $76.3M.
- Mason Hawkins's largest Q2 2026 buy was Abbott: 840,747 shares worth $76.3M.
- Mason Hawkins added most to CNX Resources in Q2 2026, an estimated $23.4M increase.
- Mason Hawkins's biggest Q2 2026 reduction was ACM Research, cutting an estimated $45.5M.
- Mason Hawkins fully exited Bio-Rad Laboratories Class A in Q2 2026, selling an estimated $45.4M.
- Mason Hawkins's ten largest holdings make up 63% of its $1.92B portfolio in Q2 2026.
- Mason Hawkins opened 2 new positions and closed 4 in Q2 2026.
- Mason Hawkins's portfolio value fell 5.7% quarter-over-quarter to $1.92B.
Based on Southeastern Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.